Close Menu
Invest Insider News
    Facebook X (Twitter) Instagram
    Tuesday, August 11
    Facebook X (Twitter) Instagram Pinterest Vimeo
    Invest Insider News
    • Home
    • Bitcoin
    • Commodities
    • Finance
    • Investing
    • Property
    • Stock Market
    • Utilities
    Invest Insider News
    Home»Investing»Cathie Wood’s ARK ETF bolsters CRISPR stock, trims Moderna By Investing.com
    Investing

    Cathie Wood’s ARK ETF bolsters CRISPR stock, trims Moderna By Investing.com

    October 18, 20242 Mins Read


    Cathie Wood’s ARK ETF published their daily trades for Thursday, October 17th, 2024, with a notable focus on the biotech sector. The most significant investment of the day was in CRISPR Therapeutics AG (NASDAQ:CRSP), where ARK bought a total of 91,665 shares across its ARKK and ARKG ETFs, amounting to a substantial $4,491,585. This purchase continues a trend for ARK, which has been consistently increasing its stake in the gene-editing company, indicating a strong conviction in CRISPR’s potential.

    Another major buy for the day was in Cerus Corp (NASDAQ:), with ARK acquiring 466,684 shares for a total value of $840,031. This move suggests a growing interest in the biomedical products company, as it was the second-largest dollar-value trade of the day.

    ARK also increased its holdings in Intellia Therapeutics Inc (NASDAQ:) by purchasing 29,739 shares valued at $612,028, further emphasizing its bet on the genomics industry. Additionally, ARK bought shares in Blade Air Mobility Inc (NASDAQ:) and 3D Systems Corp (NYSE:NYSE:), with total dollar values of $19,488 and $35,611, respectively.

    On the sell side, ARK reduced its exposure to Moderna Inc (NASDAQ:) by selling 19,544 shares for a total of $1,122,998. This follows a pattern of selling in the biotechnology company observed over the past week. ARK also continued to divest from Markforged Holding Corp (NYSE:MKFG) and Materialise NV (NASDAQ:), with sales amounting to $2,047 and $40,870, respectively.

    Investors following ARK’s trades might note the continued interest in the genomic sector, with consistent buys in companies like CRISPR Therapeutics and Intellia Therapeutics. The sales in Moderna and ongoing reductions in positions like Markforged Holding suggest a strategic shift in ARK’s portfolio composition.

    Overall, today’s trades indicate a clear focus on innovative healthcare technologies, aligning with Cathie Wood’s vision of investing in disruptive innovation. As ARK continues to adjust its holdings, market watchers and investors alike will be keen to see how these bets play out in the dynamic landscape of technological advancements.

    This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleSurge In Bitcoin Activity: Whales Transactions Hit New Highs, Is A Bull Run Brewing?
    Next Article How could the US presidential elections 2024 affect the Indian stock market?

    Related Posts

    Investing

    Earnings Signals and Labor Slowdowns: Testing the Limits of Consumer Resilience

    August 10, 2026
    Investing

    Gold prices extend big weekly advance, hit their highest levels in over two months By Investing.com

    August 10, 2026
    Investing

    Wall Street ends slightly lower, taking a beat after its best week since April By Investing.com

    August 10, 2026
    Leave A Reply Cancel Reply

    Top Posts

    How is the UK Commercial Property Market Performing?

    December 31, 2000

    How much are they in different states across the US?

    December 31, 2000

    A Guide To Becoming A Property Developer

    December 31, 2000
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews
    Bitcoin

    Nakamoto cuts debt with $48M Bitcoin sale as treasury firms prioritize balance sheet strength

    June 11, 2026
    Bitcoin

    What’s Happening? Ethereum (ETH) Unable to Break This Resistance

    August 26, 2024
    Stock Market

    Stocks higher as markets react to US-UK tariff deal

    May 8, 2025
    What's Hot

    Global stock markets fall sharply as worries grow over US recession

    August 5, 2024

    Pro Bitcoin Traders Hold Firm As BTC Bounces Off $112K

    September 30, 2025

    Historic Bitcoin Mispricing: Mathematical Model Projects 105% Returns by 2027

    February 1, 2026
    Most Popular

    L’auteur « Rich Dad Poor Dad » révèle à quel point il possède le bitcoin qu’il possède

    April 24, 2025

    Crypto Prices Slide as Bitcoin ETF Demand Softens and Ethereum Faces Scrutiny

    March 8, 2026

    Essential Utilities Announces Ed Vallejo as New Investor Relations Director

    February 28, 2025
    Editor's Picks

    Asian Stocks Set to Slide as Nvidia Disappoints: Markets Wrap

    August 28, 2024

    Stock Market Today: Nifty50 24,242, Sensex 77,733, Oil Near $108

    May 4, 2026

    Virtus Investment price target raised to $212 from $207 at Barclays

    October 27, 2024
    Facebook X (Twitter) Instagram Pinterest Vimeo
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions
    © 2026 Invest Insider News

    Type above and press Enter to search. Press Esc to cancel.